Renalytix AI plc is working with several major US academic health centers to identify kidney-related complications and long-term outcomes in patients who have survived COVID-19.
“[COVID-19] has the potential to be another cause of chronic kidney disease that needs to be addressed,” Thomas McLain, Renalytix AI’s chief
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?